Compare MSS & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MSS | BGLC |
|---|---|---|
| Founded | 2019 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4M | 10.2M |
| IPO Year | 2023 | N/A |
| Metric | MSS | BGLC |
|---|---|---|
| Price | $0.52 | $4.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.25 | N/A |
| AVG Volume (30 Days) | 165.0K | ★ 310.3K |
| Earning Date | 12-17-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $123,204,523.00 | $9,465,006.00 |
| Revenue This Year | $4.08 | N/A |
| Revenue Next Year | $7.89 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 70.01 | 2.21 |
| 52 Week Low | $0.35 | $2.01 |
| 52 Week High | $3.96 | $15.60 |
| Indicator | MSS | BGLC |
|---|---|---|
| Relative Strength Index (RSI) | 48.60 | 40.78 |
| Support Level | $0.40 | $4.11 |
| Resistance Level | $0.55 | $4.60 |
| Average True Range (ATR) | 0.05 | 0.27 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 74.22 | 31.92 |
Maison Solutions Inc is a fast-growing, specialty grocery retailer offering traditional Asian food and merchandise to modern U.S. consumers, particularly members of Asian-American communities. It is committed to providing Asian fresh produce, meat, seafood, and other daily necessities in a manner that caters to traditional Asian-American family values and cultural norms, while also accounting for the new and faster-paced lifestyle of younger generations and the diverse communities in which it operates. The company's merchandise includes fresh and, meats, seafood, and other groceries that are not found in mainstream supermarkets, including a variety of Asian vegetables and fruits such as broccoli, bitter melon, winter gourd, Shanghai baby bok choy, longan, and lychee.
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.